Literature
首页医源资料库在线期刊美国临床营养学杂志2002年76卷第2期

Evidence for impaired lipolysis in abdominally obese men: postprandial study of apolipoprotein B-48– and B-100–containing lipoproteins

来源:《美国临床营养学杂志》
摘要:s1FromtheLipidResearchCenter,LavalUniversityMedicalResearchCenter,CHULPavilion(CC,JB,andJ-PD),theDepartmentofFoodScienceandNutrition(CC,NB,NA,andJ-PD),andtheDivisionofKinesiology,DepartmentofPreventiveandSocialMedicine(AT),LavalUniversity,Qué。ABS......

点击显示 收起

Charles Couillard, Nathalie Bergeron, Agnès Pascot, Natalie Alméras, Jean Bergeron, Angelo Tremblay, Denis Prud’homme and Jean-Pierre Després

1 From the Lipid Research Center, Laval University Medical Research Center, CHUL Pavilion (CC, JB, and J-PD), the Department of Food Science and Nutrition (CC, NB, NA, and J-PD), and the Division of Kinesiology, Department of Preventive and Social Medicine (AT), Laval University, Québec; the Québec Heart Institute (AP, NA, and J-PD); and the School of Human Kinetics, Faculty of Health Sciences, University of Ottawa (DP).

2 Supported by grants from the Canadian Institutes for Health Research (MT-14014 and MGC-15187) and by the Québec Heart and Stroke Foundation. JB is a research clinical scholar from the Fonds de la Recherche en Santé du Québec (FRSQ). J-PD is chair professor of nutrition and lipidology supported by Pfizer Canada and Provigo.

3 Address reprint requests to J-P Després, Québec Heart Institute, Laval Hospital Research Center, Pavilion Marguerite-D’Youville, 4th floor, 2725 chemin Sainte-Foy, Québec, Canada G1V 4G5. E-mail: jean-pierre.despres{at}crhl.ulaval.ca.

See corresponding editorial on page 299.


ABSTRACT  
Background: Abdominal obesity has been associated with postprandial hypertriglyceridemia. The contribution of intestinally and hepatically derived lipoproteins to this exaggerated postprandial lipemic response is not known.

Objective: We examined the associations between body fatness, fat distribution, and postprandial apolipoprotein (apo) B-48 and apo B-100 concentrations measured in triacylglycerol-rich lipoproteins (TRLs).

Design: Dietary fat tolerance was investigated in 50 men aged 28–67 y. The subjects were given a test meal containing 60 g fat/m2 body surface area and providing 64% of energy from fat, 18% from carbohydrates, and 18% from protein. The meal provided 7524–9196 kJ, depending on body surface area. Blood samples were collected every 2 h over an 8-h period.

Results: The increase in plasma triacylglycerol after the meal resulted from increases in both apo B-48– and apo B-100–containing lipoproteins. The apo B-100 concentration was the strongest contributor (R2 = 69.6%, P = 0.0001) to postprandial triacylglycerol in total TRLs; the postprandial increase in triacylglycerol was best predicted by the apo B-48 concentration (R2 = 32.7%, P = 0.0001). Visceral abdominal fat was significantly associated with high postprandial TRL apo B-48 and apo B-100 concentrations (r = 0.30–0.44, P < 0.05). After the meal, the apo B-100 concentration in small TRLs decreased in 12 subjects. These men showed features of the insulin resistance–dyslipidemic syndrome, including more visceral fat (P = 0.07) and an altered fasting metabolic profile.

Conclusion: A lower lipolytic capacity may contribute to the exaggerated and prolonged postprandial lipemia among abdominally obese men.

Key Words: Abdominal obesity • visceral adipose tissue • postprandial lipemia • apolipoprotein B-48 • apolipoprotein B-100 • men • hypertriglyceridemia • triacylglycerol-rich lipoproteins


INTRODUCTION  
Abdominal obesity, especially when accompanied by an excess of visceral adipose tissue (AT), has been associated with numerous metabolic disturbances that increase the risk of cardiovascular disease (1–3). For instance, viscerally obese subjects frequently have high fasting triacylglycerol concentrations, low HDL-cholesterol concentrations, elevated apolipoprotein (apo) B and insulin concentrations, and an increased proportion of small, dense LDL particles (3–5). In addition to these disturbances in the fasting metabolic profile, abdominal obesity and excessive visceral adipose tissue accumulation have also been associated with postprandial hyperlipidemia (6–10). We previously reported that this relation is independent of obesity per se (6), and it is generally believed that the association between visceral AT and postprandial hyperlipidemia is the result of the concomitant fasting hypertriacylglycerolemia state (7, 11, 12) found in viscerally obese patients, which could delay the clearance of newly synthesized triacylglycerol-rich lipoproteins (TRLs).

Yet, although fasting hypertriacylglycerolemia may indeed be an important contributor to the increased postprandial lipemia observed in viscerally obese pateints, very little is known about the actual contribution of liver-derived compared with that of intestinally derived TRLs to the postprandial response. Because chylomicrons and VLDL show considerable variation in size and density, they cannot be adequately separated by ultracentrifugation. However, the measurement of apo B-48 and apo B-100, the structural proteins of chylomicrons and VLDL, respectively (13), allows the distinction of intestinally and hepatically derived lipoproteins. Furthermore, because each TRL particle contains only one apo B molecule, its plasma concentration has been used as a marker of lipoprotein particle number (13). Although both plasma apo B-48 and apo B-100 concentrations have been shown to increase after consumption of a high-fat meal (14–19), little is known about the relations between abdominal fat accumulation and postprandial changes in TRL particle number. Therefore, the present study was undertaken to investigate the potential associations between body fatness and AT distribution indexes and postprandial apo B-48 and apo B-100 concentrations in men.


SUBJECTS AND METHODS  
Subjects
Fifty men (mean age ± SD: 46 ± 9 y) were recruited through the media and selected to cover a wide range of body fatness values. The subjects gave their written consent to participate in the study, which was approved by the Medical Ethics Committee of Laval University. The subjects were all nonsmokers, and persons with diabetes or cardiovascular disease were excluded from the study. None of the subjects were on medication known to affect insulin action or plasma lipoprotein concentrations. With the exception of being restrained from alcohol consumption for 48 h and from physical activity for 24 h before the test meal, no dietary recommendations were made to the subjects before the study.

Anthropometry, body composition, and body fat distribution
Body weight, height, and waist and hip circumferences were measured by following standardized procedures (20). Body density was measured by the hydrostatic weighing technique (21). The mean of 6 measurements was used in the calculation of percentage body fat from body density with the use of the equation of Siri (22). Fat mass was obtained by multiplying body weight by percentage body fat. Abdominal visceral and subcutaneous AT accumulations were assessed by computed tomography, which was performed on a Siemens Somatom DRH scanner (Erlagen, Germany) with the use of previously described procedures (23, 24).

Oral lipid tolerance test
After the subjects fasted for 12 h overnight, blood was drawn by an intravenous catheter inserted into their forearm veins for sampling. Each participant was given a test meal containing 60 g fat/m2 body surface area as previously described (6). The meal (total energy: 7524–9196 kJ, depending on body surface area) provided 64% of energy from fat, 18% from carbohydrates, and 18% from protein and was well tolerated by all subjects. Participants were forbidden to eat for 8 h after consumption of the meal but were given free access to water. Blood samples were drawn before the meal and every 2 h after the meal over the 8-h period.

Plasma lipoprotein concentrations
Plasma was separated immediately after blood collection by centrifugation at 2500 x g for 10 min at 4°C. Triacylglycerol and cholesterol concentrations in total plasma were determined enzymatically (Randox Co, Crumlin, United Kingdom) on an RA-500 analyzer (Bayer Corporation Inc, Tarrytown, NY), as previously described (25). Each plasma sample (4 mL) was then subjected to a 12-h ultracentrifugation (180000 x g) in a Beckman 50.3 Ti rotor (Beckman Coulter, Fullerton, CA) at 4°C in 6 mL Beckman Quickseal tubes, which yielded 2 fractions: total TRLs [density (d) < 1006 g/L] and triacylglycerol-poor lipoproteins (d >1006 g/L). The distilled water layering technique and the modified method of Ruotolo et al (26) were used to further separate the total TRL fraction into 3 subclasses of TRLs: large, medium, and small, as previously described (6). Large TRLs consist of lipoproteins with a Svedberg flotation (Sf) rate >400, whereas the medium and small TRLs have an Sf of 20–400 (26). HDL particles were isolated from the d > 1006 g/L fraction after precipitation of apo B–containing lipoproteins with heparin and manganese chloride (27). The triacylglycerol and cholesterol contents of each fraction, ie, large, medium, and small TRLs as well as HDL, were quantified by enzymatic methods on the RA-500. All lipoprotein isolation procedures were completed within 2–3 d of the fat challenge. Fasting plasma apo B concentrations were measured in plasma by the rocket immunoelectrophoretic method (28). The lyophilized serum standard for apo B measurement in plasma was prepared in our laboratory and calibrated with reference standards obtained from the Centers for Disease Control and Prevention (Atlanta). Plasma nonesterified fatty acid concentrations were measured with a colorimetric method (29).

Postprandial apolipoprotein B-48 and B-100 measurements
Apo B-48 and apo B-100 concentrations were quantified in the different TRL fractions by densitometric scanning of apo bands separated by electrophoresis in 3–10% (by wt) sodium dodecyl sulfate polyacrylamide slab gels and stained with Coomassie blue, as previously described (30, 31). Briefly, delipidated TRL fractions were solubilized with 200–300 µL sample buffer and 50-µL portions were applied in duplicate to the gels. Gel electrophoresis was carried out in the Laemmli system at 50 V/gel for 30 min and then at 75 V/gel for 60–90 min in a Mini-Protean II vertical gel apparatus (Bio-Rad Laboratories, Hercules, CA) in which 2 minigels are run simultaneously. The gels were stained for 18–22 h in trays containing 100 mL 0.25% Coomassie Blue R-250 in methanol:water:acetic acid (5:5:1, by vol) at room temperature and under constant agitation on an orbital shaker. Finally, the gels were placed between 2 sheets of cellophane gel wrap (Biodesign Inc, New York) and allowed to dry completely in a fume hood at room temperature overnight before being analyzed (30, 31). Standards used for the calculation of apo B-48 and apo B-100 were proteins from a dialyzed, delipidated narrow-cut LDL fraction (d = 1025–1055 g/L), isolated by sequential ultracentrifugation as previously described (32). Briefly, plasma (4 mL) was overlayed with d = 1025 g/L solution and ultracentrifuged at 180000 x g at 4°C for 18 h with a Beckman 50.3 Ti rotor (Beckman Coulter, Fullerton, CA) in 6-mL Beckman Quickseal tubes. The resulting top fraction (d < 1025 g/L), consisting of VLDL and remnants, was discarded. The bottom fraction (d > 1025 g/L) was recovered and ultracentrifuged under the same conditions after addition of d = 1.055 g/L solution. The top fraction was recovered as LDL, and the bottom fraction was discarded. Proteins in this narrow-cut fraction consist almost exclusively of apo B-100 with little or no contamination by apoE (30). Because human apo B-48 and apo B-100 have the same chromogenecities (31, 33), a unique apo B-100 standard curve can be used to determine their respective concentrations in the different TRL samples.

Postheparin plasma lipoprotein lipase activity
Plasma lipoprotein lipase (LPL; EC 3.1.1.34) and hepatic lipase (EC 3.1.1.3) activities were also measured on one occasion in fasted subjects, 10 min after an intravenous injection of heparin (60 IU/kg body wt). The activity was measured by using a modification of the method of Nilsson-Ehle and Ekman (34), as previously described (35) and expressed as nmol oleic acid released·mL plasma-1·min-1.

Glucose and insulin concentrations
Fasting and postprandial plasma glucose concentrations were determined with the glucose oxidase assay (Sigma, St Louis; 36). Plasma insulin concentrations were measured by a commercial double-antibody radioimmunoassay (Linco Research, St Louis) that shows little cross-reactivity (<0.02%) with proinsulin (37).

Statistical analyses
Spearman correlation coefficients were used to quantify associations between variables (nonparametric variables). Differences between negative and positive small TRL apo B-100 responders were tested by analysis of variance followed by Tukey’s studentized range test. Analysis of variance for repeated measures was also performed to test the effects of response group, time, and the response group x time interaction term on the postprandial changes in TRL composition parameters. The independent contributions of the response of postprandial total TRL apo B-48 and apo B-100 to the variance of the postprandial plasma triacylglycerol response were quantified by multiple regression analyses. Total TRL data were calculated by summing individual values of the large, medium, and small TRL fractions and the different areas under the total (AUC) and incremental curves of TRL. Triacylglycerol, apo B-48, and apo B-100 concentrations were determined by the trapezoid method. All analyses were conducted with the SAS statistical package (version 8.0; SAS Institute, Cary, NC).


RESULTS  
The physical and metabolic characteristics of the men recruited for the study are shown in Table 1. By design, the group had a wide range of body fatness and fat distribution values. As a group, the subjects were abdominally obese, as shown by high mean values for waist circumference (100 cm), and had visceral AT accumulation higher than the 130-cm2 proposed cutpoint value associated with a higher risk of metabolic disturbances (3). The fasting metabolic profile was also concordant with that generally found among men with abdominal obesity. Indeed, the subjects had moderately elevated fasting plasma triacylglycerol (2.0 mmol/L), low HDL-cholesterol (0.9 mmol/L), and high apo B (1.0 g/L) and insulin (100 pmol/L) concentrations.


View this table:
TABLE 1 . Physical characteristics and fasting metabolic profile of the subjects1  
Postprandial triacylglycerol and cholesterol concentrations in total TRLs (d < 1006 g/L) are presented in Figure 1. We noted significant increases in plasma concentrations of these variables after meal consumption. However, the rise in total TRL triacylglycerol was greater (2.4-fold increase from fasting to the 6-h peak concentration, P < 0.0001) than the change in total TRL cholesterol (1.1-fold increase at 6 h, P < 0.0001). In addition, this increase in the triacylglycerol content of total TRLs resulted from increases in both intestinal and hepatic TRL particles, as indicated by the concomitant elevation of apo B-48 (1.4-fold increase, P < 0.0001) and apo B-100 (0.5-fold increase, P < 0.0001) concentrations. Although both apo B-48 and apo B-100 concentrations increased during the postprandial period, 85% of the postprandial increase in particle number was accounted for by apo B-100–containing TRLs, and apo B-48–containing TRLs accounted for only 15% of this increase. Postprandial total and incremental responses of triacylglycerol, apo B-48, and apo B-100 in total TRLs are shown in Table 2.


View larger version (13K):
FIGURE 1. . Postprandial triacylglycerol (•), cholesterol (), apolipoprotein (apo) B-48 (), and apo B-100 () concentrations in total triacylglycerol-rich lipoproteins (TRLs) in the group of 50 men. Values are presented as means ± SEM. *Significantly different from baseline, P < 0.0001.

 

View this table:
TABLE 2 . Total area under the curve and total area under the incremental curve of postprandial triacylglycerol, apolipoprotein (apo) B-48, and apo B-100 concentrations in total triacylglycerol-rich lipoproteins (TRLs)1  
The results of the multiple regression analyses conducted to quantify the independent contributions of postprandial total TRL apo B-48 and apo B-100 concentrations to the variance in postprandial total TRL triacylglycerol concentrations are shown in Table 3. Postprandial total TRL apo B-100 AUC was by far the best predictor of postprandial total TRL triacylglycerol concentrations, accounting for 70% of the variance. In contrast, the area under the incremental curve of total TRL apo B-48 concentrations showed the greatest contribution to the response of total TRL triacylglycerol.


View this table:
TABLE 3 . Multivariate regression analyses showing the independent contributions of postprandial apolipoprotein (apo) B-48 and apo B-100 concentrations to the postprandial triacylglycerol concentrations in total triacylglycerol-rich lipoproteins (TRLs)  
Associations between body composition, fat distribution indexes, and postprandial apo B-48 and apo B-100 AUC in total TRLs as well as in the large, medium, and small TRL fractions are presented in Table 4. Total body fat mass, expressed in kilograms, showed no association with postprandial apo B-48 AUC but was significantly associated with a greater apo B-100 AUC in all TRL fractions, although this relation was not statistically significant in the small TRL fraction. In contrast, preferential accumulation of fat in the abdominal region, expressed as a high waist circumference, was positively correlated with both apo B-48 and apo B-100 concentrations during the postprandial period with the exception of the small TRL fraction. Furthermore, whereas no association was found between postprandial apo B-48 and apo B-100 AUC and the amount of abdominal subcutaneous AT, greater visceral AT accumulation was accompanied by a larger postprandial AUC of both apo B-48 and apo B-100 concentrations in all TRL fractions (Table 4).


View this table:
TABLE 4 . Spearman correlation coefficients between body composition, adipose tissue distribution, and postprandial area under the curve (AUC) of apolipoprotein (apo) B-48 and apo B-100 concentrations in triacylglycerol-rich lipoproteins (TRLs)  
Fasting plasma lipoprotein-lipid concentrations as well as insulin and glucose concentrations were also associated with postprandial apo B-48 and apo B-100 AUC (Table 5). Elevated fasting plasma apo B, glucose, and insulin concentrations were associated with exaggerated postprandial apo B-48 and apo B-100 AUC in all TRL fractions. Low fasting HDL cholesterol and an increased total-HDL cholesterol ratio were also associated with greater postprandial AUC for both apo B-48 and apo B-100. Nevertheless, fasting triacylglycerol was undoubtedly the best correlate of both postprandial apo B-48 and apo B-100 AUC, an observation that is reinforced by the fact that statistical adjustment for fasting triacylglycerol concentrations eliminated almost all associations between the metabolic variables measured and postprandial apo B-48 and apo B-100 AUC (data not shown).


View this table:
TABLE 5 . Spearman correlation coefficients between fasting metabolic profile variables and the postprandial area under the curve (AUC) of apolipoprotein (apo) B-48 and apo B-100 concentrations in triacylglycerol-rich lipoproteins (TRLs)  
The associations between the postprandial response or area under the incremental curve of triacylglycerol and apo B-100 in large, medium, and small TRLs are shown in Figure 2. We found positive and significant associations between both variables in the large and medium TRL fractions. Similar correlations were observed between the triacylglycerol and apo B-48 responses in large, medium, and small TRLs (data not shown). However, postprandial triacylglycerol and apo B-100 responses were not associated in the small TRL fraction, suggesting that an increase in the number of apo B-100–containing particles was not a major contributing factor in the significant increase in triacylglycerol within that specific TRL fraction.


View larger version (20K):
FIGURE 2. . Associations between triacylglycerol and apolipoprotein (apo) B-100 responses (area under the incremental curve) in large (r = 0.76, P < 0.0001), medium (r = 0.51, P < 0.0005), and small (r = 0.09) triacylglycerol-rich lipoproteins (TRLs) in the group of 50 men. The subjects were separated on the area under the incremental curve of small TRL apo B into positive (•) and negative () responders.

 
The results presented in Figure 2 also showed that some individuals were characterized by a negative response of small TRL apo B-100 concentrations, suggesting a reduction in the absolute number of small TRL particles in these subjects after the meal. This was noted despite the fact that these subjects also showed an increase in the triacylglycerol content of that same TRL fraction. To further investigate this observation, we matched subjects on the basis of their triacylglycerol response but separated them on the basis of their apo B-100 response in small TRLs (positive compared with negative response). Postprandial apo B-48 and apo B-100 concentrations in large, medium, and small TRLs and the triacylglycerol response for these respective TRL fractions in positive or negative small TRL apo B-100 responders are shown in Figure 3. We found that negative small TRL apo B-100 responders showed larger apo B-100, apo B-48, and triacylglycerol responses in large and medium TRLs compared with positive small TRL apo B-100 responders. Analysis of variance for repeated measures was performed to test the respective effects of response group (negative compared with positive responders) and time variables as well as of the time x group interaction term on postprandial apo B-48 and B-100 concentrations within the different TRL fractions. Significant group effects were noted for all TRL apo B concentrations, with the exception of apo B-48 in small TRLs, indicating that concentrations of both apolipoproteins during the postprandial period were significantly different between negative and positive responders. Furthermore, significant time x group interaction terms were found in large (apo B-48: P = 0.0110; apo B-100: P = 0.0094) and small TRL (apo B-48: P = 0.0186; apo B-100: P = 0.0001) fractions but not in medium TRLs. These results suggest that the accumulation of large TRL particles was greater in negative than in positive small TRL apo B-100 responders.


View larger version (27K):
FIGURE 3. . Postprandial apolipoprotein (apo) B-48 and apo B-100 concentrations and triacylglycerol responses (area under the incremental curve) in large (A), medium (B), and small (C) triacylglycerol-rich lipoproteins (TRLs) in men matched for small TRL triacylglycerol response but with either a positive (•, n = 11) or negative (, n = 11) apo B-100 response in small TRLs after the meal. Values are presented as means ± SEM. *, **, ***Significantly different from men with a negative small TRL apo B-100 response: *P < 0.05, **P < 0.005, ***P < 0.01.

 
As shown in Table 6, subjects with a postprandial decrease in small TRL apo B-100 concentrations tended to be characterized by higher visceral AT accumulation than were subjects with a positive response. High fasting triacylglycerol, insulin, total TRL apo B-48 and apo B-100 concentrations, lower HDL-cholesterol concentrations, and a higher total-HDL cholesterol ratio also characterized men with a postprandial decrease in the number of apo B-100–containing small TRL particles. The postprandial changes in the ratio of triacylglycerol to apo B (B-48 + B-100) in total TRLs in negative and positive small TRL apo B-100 responders are shown in Figure 4. We observed that from the 4-h time point, negative small TRL apo B-100 responders were characterized by higher total TRL triacylglycerol–apo B ratios than were positive responders. These results were concordant with the lower (P < 0.05) postheparin LPL activity found in negative than in positive small TRL apo B-100 responders (Figure 4).


View this table:
TABLE 6 . Features of the insulin resistance–dyslipidemic syndrome in men matched on the basis of their postprandial apolipoprotein (apo) B response area under the incremental curve in small triacylglycerol-rich lipoproteins (TRLs)1  

View larger version (20K):
FIGURE 4. . Postprandial changes in the ratio of triacylglycerol to apolipoprotein (apo) B (B-48 + B-100) in all triacylglycerol-rich lipoproteins (TRLs; left) and postheparin plasma lipoprotein lipase (LPL; right) in men matched for small TRL triacylglycerol response but with either a positive (•, n = 11) or negative (, n = 11) apo B-100 response in small TRLs after the meal. Values are presented as means ± SEM. *, **Significantly different from men with a positive small TRL apo B-100 response: *P < 0.05, **P < 0.005.

 

DISCUSSION  
The results of the present study show that the postprandial increase in total TRL triacylglycerol concentrations results from increases of both intestinally and hepatically derived TRL particles. The contribution of TRLs produced by the liver to postprandial triacylglycerol was previously reported (15, 19, 38). In our study, liver-derived TRLs (containing apo B-100) accounted for most of the increase in particle number postprandially. However, in stepwise multiple regression analysis, the increase in postprandial total TRL triacylglycerol was best predicted by the apo B-48 response to the fat load rather than by the rise in apo B-100 concentrations in total TRLs. In accordance with our results, it had been suggested that apo B-100 TRLs are responsible for transporting a significant proportion of triacylglycerol during the postprandial period but that the increase in plasma TRL triacylglycerol concentrations in the fed state is predominantly the result of an increase in apo B-48–containing TRLs (19, 38). This hypothesis was later confirmed in a study that used immunoaffinity chromatography to separate apo B-48– from apo B-100–containing TRLs; the investigators reported that although both apo B-48– and apo B-100–containing TRLs contribute to postprandial lipemia, particles containing apo B-48 account for most of the increase in triacylglycerol postprandially (39). Our results on the contribution of apo B-48 and apo B-100 concentrations to postprandial triacylglycerolmia are concordant with these previous observations.

Visceral fat has been associated with postprandial hypertriacylglycerolemia (6, 7, 9). The results of the present study show that an excessive accumulation of fat in the abdominal region is also associated with an increase in the number of apo B-48– and apo B-100–containing TRL particles after a meal. Furthermore, visceral obesity could be an important factor contributing to such a relation. Indeed, visceral but not subcutaneous abdominal AT accumulation was significantly associated with high apo B-48 and apo B-100 concentrations during the postprandial phase. To the best of our knowledge, this association, derived with the use of apoprotein markers of TRLs of intestinal compared with hepatic origin, was not reported before.

The well-documented importance of fasting triacylglycerol concentrations in postprandial hyperlipidemia (6, 11, 12) is also underlined in the present study, because this was the variable that best predicted postprandial apo B-48 and apo B-100 responses. Because fasting hypertriacylglycerolemia is a common feature of visceral obesity (1, 2), these high fasting triacylglycerol concentrations could explain, at least in part, the associations between abdominal obesity, visceral AT accumulation, and postprandial TRL particle number. A plausible physiologic mechanism has been proposed to explain these associations. Visceral adipocytes are characterized by a lively lipolytic activity that is poorly inhibited by insulin, resulting in an increase of nonesterified fatty acids in the portal circulation and in the plasma (40). Furthermore, Basu et al (41) recently reported that abdominal subcutaneous AT supplies an important quantity of nonesterified fatty acids to the systemic circulation. The increased flux of nonesterified fatty acids to the liver would elevate triacylglycerol concentrations through increased esterification of nonesterified fatty acids, reduced hepatic degradation of apo B, and ultimately overproduction of VLDL particles by the liver. This hypothesis is further supported by previously published reports of an impaired postprandial plasma nonesterified fatty acid metabolism in upper-body obesity (6, 42). On their entry into the circulation, both newly synthesized and endogenous TRLs have been shown to compete for LPL to be hydrolyzed (43); thus, the increased number of TRL particles in the fasting state could contribute to delaying the clearance of both apo B-48 and apo B-100 TRLs during the postprandial period, as previously proposed (44).

In the present study, 1 of 4 subjects was characterized by a negative response of small TRLs (mainly due to a decrease in apo B-100–containing particles) and a positive triacylglycerol response in small TRLs. In other words, the significant increase in the triacylglycerol content of small TRLs after the meal was not associated with an increase in the absolute number of small TRL particles. This postprandial lowering of small TRL apo B-100 supports previous observations by Björkegren et al (45) in nonobese hypertriglyceridemic subjects. When compared with subjects matched for their postprandial triacylglycerol response in small TRLs but with a concomitant increase in small TRL apo B-100 (positive responders), individuals with a negative small TRL apo B-100 response (negative responders) were characterized by features of the insulin resistance–dyslipidemic syndrome such as higher visceral fat deposition, although the difference was not statistically significant (P = 0.07), higher fasting triacylglycerol and insulin concentrations, and a higher total-HDL cholesterol ratio. They also had more intestinally and hepatically derived TRL particles in the fasting state, as revealed by their higher total TRL apo B-48 and apo B-100 concentrations, respectively.

On the other hand, LPL, an enzyme closely related to the hydrolysis of triacylglycerol from chylomicrons and VLDL, was also shown to promote the hepatic clearance of TRL particles (46). Lower LPL activity of small TRL apo B-100 in negative than in positive responders could prevent the formation of smaller TRL particles through reduction of the hydrolysis of larger particles and thus explain the fall in small TRL apo B-100 concentrations. This concept was previously proposed for nonobese individuals (44, 45), and our observations tend to support such a hypothesis because larger TRL particles accumulated after the meal in the negative responders.

In summary, the present study confirms previous observations that increases in both apo B-48– and apo B-100–containing TRLs contribute to postprandial lipemia. Furthermore, our results also indicate that abdominal fat accumulation, particularly in the presence of an excess of visceral AT, is associated with a higher number of postprandial apo B-48 (intestinal) and apo B-100 (hepatic) TRL particles. Results in the literature suggest that the insulin-resistant state associated with visceral obesity could promote the production of VLDL particles by the liver, possibly causing saturation of the lipolytic pathway. Reduced LPL activity per se may also lead to the accumulation of larger TRL particles during the postprandial period in abdominally obese subjects. Consequently, postprandial alterations in the catabolism of apo B-48 and apo B-100 particles in abdominally obese men are likely to induce triacylglycerol enrichment of LDL and HDL cholesterol and subsequently produce smaller, denser LDL and HDL particles, which have the potential to increase the risk of cardiovascular disease.


ACKNOWLEDGMENTS  
We thank the staff of the Physical Activity Sciences Laboratory for data collection and the personnel of the Lipid Research Center for their excellent and dedicated contribution to the study.


REFERENCES  

  1. Björntorp P. Abdominal fat distribution and disease: an overview of epidemiological data. Ann Med 1992;24:15–8.
  2. Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev 1994;74:761–811.
  3. Després JP, Lamarche B. Effects of diet and physical activity on adiposity and body fat distribution: implications for the prevention of cardiovascular disease. Nutr Res Rev 1993;6:137–59.
  4. Lemieux I, Pascot A, Couillard C, et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 2000;102:179–84.
  5. Tchernof A, Lamarche B, Prud’Homme D, et al. The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Diabetes Care 1996;19:629–37.
  6. Couillard C, Bergeron N, Prud’homme D, et al. Postprandial triglyceride response in visceral obesity in men. Diabetes 1998;47:953–60.
  7. Couillard C, Bergeron N, Prud’homme D, et al. Gender difference in postprandial lipemia—importance of visceral adipose tissue accumulation. Arterioscler Thromb Vasc Biol 1999;19:2448–55.
  8. Mekki N, Christofilis MA, Charbonnier M, et al. Influence of obesity and body fat distribution on postprandial lipemia and triglyceride-rich lipoproteins in adult women. J Clin Endocrinol Metab 1999;84:184–91.
  9. Ryu JE, Craven TE, MacArthur RD, et al. Relationship of intraabdominal fat as measured by magnetic resonance imaging to postprandial lipemia in middle-aged subjects. Am J Clin Nutr 1994;60:586–91.
  10. Wideman L, Kaminsky LA, Whaley MH. Postprandial lipemia in obese men with abdominal fat patterning. J Sports Med Phys Fitness 1996;36:204–10.
  11. Couillard C, Bergeron N, Bergeron J, et al. Metabolic heterogeneity underlying postprandial lipemia among men with low fasting high density lipoprotein cholesterol concentrations. J Clin Endocrinol Metab 2000;85:4575–82.
  12. Lewis GF, O’Meara NM, Soltys PA, et al. Fasting hypertriglyceridemia in non-insulin-dependent diabetes mellitus is a important predictor of postprandial lipid and lipoprotein abnormalities. J Clin Endocrinol Metab 1991;72:934–44.
  13. Karpe F, Hamsten A. Postprandial lipoprotein metabolism and atherosclerosis. Curr Opin Lipidol 1995;6:123–9.
  14. Phillips C, Murugasu G, Owens D, Collins P, Johnson A, Tomkin GH. Improved metabolic control reduces the number of postprandial apolipoprotein B-48-containing particles in type 2 diabetes. Atherosclerosis 2000;148:283–91.
  15. Karpe F, Hellenius ML, Hamsten A. Differences in postprandial concentrations of very-low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease. Metabolism 1999;48:301–7.
  16. Mero N, Syvänne M, Eliasson B, Smith U, Taskinen MR. Postprandial elevation of ApoB-48-containing triglyceride-rich particles and retinyl esters in normolipemic males who smoke. Arterioscler Thromb Vasc Biol 1997;17:2096–102.
  17. Mero N, Malmström R, Steiner G, Taskinen MR, Syvänne M. Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease. Atherosclerosis 2000;150:167–77.
  18. Karpe F, Bell M, Björkegren J, Hamsten A. Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labelling and simultaneous measurement of apolipoprotein B-48 and B-100. Arterioscler Thromb Vasc Biol 1995;15:199–207.
  19. Schneeman BO, Kotite L, Todd KM, Havel RJ. Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoprotein B-48 and B-100 to a fat-containing meal in normolipidemic humans. Proc Natl Acad Sci U S A 1993;90:2069–73.
  20. van der Kooy K, Seidell JC. Techniques for the measurement of visceral fat: a practical guide. Int J Obes 1993;17:187–96.
  21. Behnke AR, Wilmore JH. Evaluation and regulation of body build and composition. Englewood Cliffs, NJ: Prentice-Hall, 1974.
  22. Siri W. The gross composition of the body. Adv Biol Med Phys 1956;4:239–80.
  23. Després JP, Prud’homme D, Pouliot MC, Tremblay A, Bouchard C. Estimation of deep abdominal adipose-tissue accumulation from simple anthropometric measurements in men. Am J Clin Nutr 1991;54:471–7.
  24. Ferland M, Després JP, Tremblay A, et al. Assessment of adipose tissue distribution by computed axial tomography in obese women: association with body density and anthropometric measurements. Br J Nutr 1989;61:139–48.
  25. Moorjani S, Dupont A, Labrie F, et al. Increase in plasma high-density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma. Metabolism 1987;36:244–50.
  26. Ruotolo G, Zhang H, Bentsianov V, Le NA. Protocol for the study of the metabolism of retinyl esters in plasma lipoproteins during postprandial lipemia. J Lipid Res 1992;33:1541–9.
  27. Burstein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 1970;11:583–95.
  28. Avogaro P, Bon GB, Cazzolato G, Quinci GB. Are apolipoproteins better discriminators than lipids for atherosclerosis? Lancet 1979;1:901–3.
  29. Noma A, Okabe H, Kita M. A new colorimetric micro-determination of free fatty acids in serum. Clin Chim Acta 1973;43:317–20.
  30. Bergeron N, Kotite L, Havel RJ. Simultaneous quantification of apolipoproteins B-100, B-48 and E separated by SDS-PAGE. Methods Enzymol 1996;263:82–94.
  31. Kotite L, Bergeron N, Havel RJ. Quantification of apolipoproteins B-100, B-48 and E in human triglyceride-rich lipoproteins. J Lipid Res 1995;36:890–900.
  32. Havel RJ, Eder H, Bragdon J. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345–53.
  33. Zilversmit DB, Shea TM. Quantitation of apoB-48 and apoB-100 by gel scanning or radio- iodination. J Lipid Res 1989;30:1639–46.
  34. Nilsson-Ehle P, Ekman R. Specific assays for lipoprotein lipase and hepatic lipase activities of post-heparin plasma. In: Peeters H, ed. Protides of biological fluids. Oxford, United Kingdom: Permagon Press, 1978:243–6.
  35. St-Amand J, Després JP, Lemieux S, et al. Does lipoprotein or hepatic lipase activity explain the protective lipoprotein profile of premenopausal women? Metabolism 1995;44:491–8.
  36. Raabo E, Terkildsen TC. On the enzymatic determination of blood glucose. Scand J Clin Lab Invest 1960;12:402–7.
  37. Morgan CR, Lazarow A. Immunoassay of insulin—two antibody system. Plasma insulin levels in normal, subdiabetic rats. Diabetes 1963;12:115–26.
  38. Cohn JS, Johnson EJ, Millar JS, et al. Contribution of apo B-48 and apo B-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentrations of TRL triglycerides and retinyl esters. J Lipid Res 1993;34:2033–40.
  39. Bergeron N, Havel RJ. Influence of diets rich in saturated and omega-6 polyunsaturated fatty acids on the postprandial responses of apolipoproteins B-48, B-100, E, and lipids in triglyceride-rich lipoproteins. Arterioscler Thromb Vasc Biol 1995;12:2111–21.
  40. Rebuffé-Scrive M, Lönnorth P, Marin P, Wesslau C, Björntorp P, Smith U. Regional adipose tissue metabolism in men and postmenopausal women. Int J Obes 1987;11:347–55.
  41. Basu A, Basu R, Shah P, Vella A, Rizza RA, Jensen MD. Systemic and regional free fatty acid metabolism in type 2 diabetes. Am J Physiol 2001;280:E1000–6.
  42. Roust LR, Jensen MD. Postprandial free fatty acid kinetics are abnormal in upper body obesity. Diabetes 1993;42:1567–73.
  43. Brunzell JD, Hazzard WR, Porte D Jr, Bierman EL. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. J Clin Invest 1973;52:1578–85.
  44. Björkegren J, Packard CJ, Hamsten A, et al. Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway. J Lipid Res 1996;37:76–86.
  45. Björkegren J, Hamsten A, Milne RW, Karpe F. Alterations of VLDL composition during alimentary lipemia. J Lipid Res 1997;38:301–14.
  46. Goldberg IJ. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 1996;37:693–707.
Received for publication August 30, 2001. Accepted for publication January 30, 2002.


Related articles in AJCN:

Postprandial lipemia and obesity—any unique features?
Lars Berglund
AJCN 2002 76: 299-300. [Full Text]  

作者: Charles Couillard
医学百科App—中西医基础知识学习工具
  • 相关内容
  • 近期更新
  • 热文榜
  • 医学百科App—健康测试工具